Balyasny Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-327,045
| Closed | -$15.7M | – | 1476 |
|
|
2020
Q1 | $15.7M | Buy |
327,045
+135,708
| +71% | +$6.52M | 0.19% | 147 |
|
|
2019
Q4 | $8.98M | Buy |
+191,337
| New | +$8.98M | 0.05% | 408 |
|
|
2018
Q2 | – | Sell |
-28,997
| Closed | -$154K | – | 2070 |
|
|
2018
Q1 | $154K | Sell |
28,997
-4,703
| -14% | -$25K | ﹤0.01% | 1605 |
|
|
2017
Q4 | $286K | Buy |
+33,700
| New | +$286K | ﹤0.01% | 1520 |
|
|
2017
Q2 | – | Sell |
-14,170
| Closed | -$302K | – | 1623 |
|
|
2017
Q1 | $302K | Buy |
14,170
+590
| +4% | +$12.6K | ﹤0.01% | 1231 |
|
|
2016
Q4 | $206K | Buy |
+13,580
| New | +$206K | ﹤0.01% | 1086 |
|